Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals Inc.
WKN: 881535 / Symbol: REGN / Name: Regeneron / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
599,80 €
1,27 %
Regeneron Pharmaceuticals (REGN) had its price target lowered by Barclays PLC from $923.00 to $917.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals (REGN) had its price target lowered by Piper Sandler from $875.00 to $855.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals (REGN) had its price target lowered by JPMorgan Chase & Co. from $950.00 to $850.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals (REGN) had its price target lowered by Truist Financial Corporation from $796.00 to $778.00. They now have a "buy" rating on the stock.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals (REGN) had its price target lowered by BMO Capital Markets from $900.00 to $730.00. They now have an "outperform" rating on the stock.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals (REGN) had its price target lowered by Canaccord Genuity Group Inc. from $1,057.00 to $875.00. They now have a "buy" rating on the stock.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals (REGN) had its price target lowered by Cantor Fitzgerald from $785.00 to $750.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals (REGN) had its price target lowered by HSBC Holdings plc from $990.00 to $880.00. They now have a "buy" rating on the stock.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals (REGN) was upgraded by Benchmark Co. from "hold" to "buy". They now have a $185.00 price target on the stock.
Ratings data for REGN provided by MarketBeat
Neueste Beiträge
Evercore_Inc_ in Dell Technologies Inc diskutieren